TE_32054
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1MB7_3end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | -, DOC2B |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 0.05 |
| Counts of samples | TCGA_tumor:243; TCGA_normal:10; GTEx:5535 |
| TSS | chr17(-):154477 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_32054.1 | - | Intergenic | Non-coding | Non-coding | chr17(-):154128,154148,154186,154407,154445,154478 |
| teRNA_32054.2 | DOC2B | Chimeric | Non-coding | Non-coding | chr17(-):147557,147577,148173,148269,149111,149192,149856,154407,154445,154478 |
| teRNA_32054.3 | DOC2B | Chimeric | Non-coding | Non-coding | chr17(-):147557,147577,148173,148269,149111,149192,149856,154148,154186,154407,154445,154478 |
| teRNA_32054.4 | DOC2B | Chimeric | Non-coding | Non-coding | chr17(-):147557,147577,148173,148269,149111,154185,154260,154407,154445,154478 |
| teRNA_32054.5 | DOC2B | Chimeric | Non-coding | Non-coding | chr17(-):147557,147577,148173,148269,149111,149192,152948,154185,154223,154407,154445,154478 |
| teRNA_32054.6 | DOC2B | Chimeric | Non-coding | Non-coding | chr17(-):147557,147577,148173,148269,149111,149192,152948,154407,154445,154478 |
| teRNA_32054.7 | DOC2B | Chimeric | Non-coding | Non-coding | chr17(-):147557,147577,148173,148269,149111,154407,154445,154478 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
